Description
Rivaroxaban is a highly selective direct Factor Xa inhibitor. Inhibition of Factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibiting both thrombin formation and development of thrombi. Rivaroxaban does not inhibit thrombin (activated Factor II) and has no effects on platelets.
Additional information
| brand | Pharmevo (Private) |
|---|
